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n 
 
dystrophic
 
 mice, a model of merosin-deﬁcient congenital
muscular dystrophy, laminin-2 mutations produce periph-
eral nerve dysmyelination and render Schwann cells
unable to sort bundles of axons. The laminin receptor and
the mechanism through which dysmyelination and impaired
sorting occur are unknown. We describe mice in which
 
Schwann cell–speciﬁc disruption of 
 
 
 
1 integrin, a component
of laminin receptors, causes a severe neuropathy with
impaired radial sorting of axons. 
 
 
 
1-null Schwann cells
I
 
populate nerves, proliferate, and survive normally, but do
not extend or maintain normal processes around axons.
Interestingly, some Schwann cells surpass this problem to
form normal myelin, possibly due to the presence of other
laminin receptors such as dystroglycan and 
 
 
 
6
 
 
 
4 integrin.
These data suggest that 
 
 
 
1 integrin links laminin in the
basal lamina to the cytoskeleton in order for Schwann cells
to ensheath axons, and alteration of this linkage contributes to
the peripheral neuropathy of congenital muscular dystrophy.
 
Introduction
 
Myelination in the peripheral nervous system is accom-
plished by Schwann cells. In embryonic nerves, Schwann
cell precursors originate from neural crest cells and migrate
along growing neurites. Neurites and Schwann cells contact
and influence each other, reciprocally determining survival
and differentiation (for review see Jessen and Mirsky, 1999;
Witt and Brady, 2000). Before birth, Schwann cells send cy-
toplasmic processes into bundles of axons, and progressively
sort individual axons so that a 1:1 relationship is established
(promyelinating Schwann cells) in a process termed radial
sorting (Webster, 1984). Axons that are destined to remain
unmyelinated are ensheathed in groups by nonmyelinating
Schwann cells. Assignment of one or the other Schwann
cell–axon relationship is largely complete within the first few
days after birth in the rodent (Webster, 1984). Both types of
Schwann cells deposit and organize a basal lamina, but only
promyelinating Schwann cells proceed to wrap concentric ex-
tensions of their membrane around axons, to produce myelin.
Bunge and Bunge (1983) proposed that Schwann cells re-
semble epithelia: they separate neurons from mesenchymal
tissues by forming a basal lamina, and polarize their surfaces
into an ab-axonal surface (similar to the basal surface of epi-
thelia) contacting the basal lamina and an ad-axonal surface
(similar to the apical surface of epithelia) contacting the
axon. Subsequent studies showed that Schwann cells require
the formation of an organized basal lamina (for review see
Bunge, 1993), or at least laminin deposition (Podratz et al.,
2001), to properly ensheath and myelinate dorsal root gan-
glion neurons (DRG)* in coculture. In support of this, the
 
dystrophic
 
 (
 
dy/dy
 
 and 
 
dy
 
2J
 
/
 
dy
 
2J
 
) mice and merosin-deficient
congenital muscular dystrophy (CMD) patients harbor mu-
tations in the gene encoding the 
 
 
 
2 laminin chain (
 
dy
 
2J
 
/
 
dy
 
2J
 
and CMD) that result in absent or defective laminin-2
(Xu et al., 1994; Helbling-Leclerc et al., 1995; Sunada et al.,
1995) and cause muscular dystrophy (Michelson et al.,
1955). Both the mouse and human disorders include a
dysmyelinating peripheral neuropathy (Bradley and Jenkison,
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1973). The most striking abnormality in 
 
dystrophic
 
 mice is
present in spinal roots and cranial nerves, and to a lesser ex-
tent in peripheral nerves, where bundles of naked axons are
not invested by any Schwann cell processes (Bradley and
Jenkison, 1973). Basal laminae are discontinuous both in
roots and peripheral nerves (Madrid et al., 1975). Despite
extensive studies (Perkins et al., 1981), the mechanism for
these abnormalities has not been elucidated. In particular,
which laminin receptors determine the ability of Schwann
cells to ensheath or myelinate axons is unclear.
Myelin-forming Schwann cells synthesize abundantly the
laminin receptors 
 
 
 
6
 
 
 
4, 
 
 
 
6
 
 
 
1 integrins and dystroglycan,
and minor amounts of 
 
 
 
2
 
 
 
1 integrin (for review see Previ-
tali et al., 2001). 
 
 
 
1 integrin can dimerize with several 
 
 
 
subunits, forming receptors for many extracellular matrix
components in addition to laminins (for review see Previtali
et al., 2001). 
 
 
 
1 integrins, including 
 
 
 
6
 
 
 
1, are detectable in
the Schwann cell lineage from its first appearance (Bronner-
fraser et al., 1992) and may play various roles in peripheral
nerve development and myelination (Previtali et al., 2001).
For example, antibodies to 
 
 
 
1 integrin block myelination in
neuronal-Schwann cell cocultures (Fernandez-Valle et al.,
1994), although 
 
 
 
1 is also present on axons (Tomaselli et
al., 1993); the effect may be non-Schwann cell autonomous.
Genetic studies of the role for 
 
 
 
1 integrin in nerve develop-
ment have been impossible, since targeted inactivation of 
 
 
 
1
in mouse causes early embryonic death (Fassler and Meyer,
1995; Stephens et al., 1995).
Here, we report inactivation of 
 
 
 
1 integrin specifically in
Schwann cells using the Cre-
 
lox
 
P system, and show that 
 
 
 
1
integrins are crucially important for Schwann cell–axon in-
teractions. In the absence of 
 
 
 
1 integrin, Schwann cells can
populate nerves, proliferate, and survive normally, but can-
not segregate axons, and leave fetal nerve–like bundles of ax-
ons in nerves of adult mice. Many Schwann cells form a
basal lamina and initiate process extension and ensheath-
ment of axons, but are unable to maintain extension and re-
tract their processes. Intriguingly, these nerves closely resem-
ble the roots and proximal nerves of 
 
dystrophic
 
 mice. Finally,
we show that the few Schwann cells that achieve a 1:1 rela-
tionship with an axon can myelinate in the complete absence
of 
 
 
 
1 integrin. These data suggest a role for the cytoskeleton
in the pathogenesis of neuropathy associated with CMD.
 
Results
 
Generation of mice lacking 
 
 
 
1 integrin 
in Schwann cells
 
To inactivate the 
 
Itg
 
 
 
1
 
 gene only in Schwann cells, we
crossed mice homozygous for 
 
 
 
1 “floxed” (the first coding
exon was flanked by two 
 
lox
 
P sites [
 
 
 
1
 
F/F
 
]) with mice het-
erozygous for the 
 
 
 
1 null allele and hemizygous for a P
 
0
 
Cre
transgene (
 
 
 
1
 
 
 
/
 
 
 
//P
 
0
 
Cre) (Fig. 1 A). 
 
 
 
1
 
F/F
 
 and 
 
 
 
1
 
 
 
/
 
 
 
 mice
appear normal (Stephens et al., 1995; Graus-Porta et al.,
2001). Our P
 
0
 
Cre transgene, mP
 
0
 
TOT(Cre), is based on the
whole P
 
0
 
 glycoprotein gene, and activates Cre-mediated re-
combination specifically in Schwann cells between embry-
onic days (E)13.5 and 14.5 (Feltri et al., 1999a). 
 
 
 
1
 
F/
 
 
 
//
P
 
0
 
Cre (mutant) mice were generated in accord with Mende-
lian ratios, and were thus viable.
 
P
 
0
 
Cre disrupts 
 
 
 
1 integrin specifically in Schwann cells
 
To verify the extent of 
 
 
 
1 recombination in peripheral
nerves, transverse sections of sciatic nerves from mutant and
control mice were stained for 
 
 
 
1 integrin at postnatal day
(P)28. In control nerves, 
 
 
 
1 integrin was detected in the en-
doneurium on the outer surface of Schwann cells and in
blood vessels, and in the perineurium (Fig. 1 B). In contrast,
in mutant nerves, 
 
 
 
1 integrin was nearly absent in the endo-
neurium, whereas it remained easily detected in the perineu-
rium (Fig. 1 C). Endoneurial 
 
 
 
1 staining was accounted for
by blood vessels and by perineurial cells not normally
Figure 1. Disruption of  1 integrin specifically in Schwann cells 
in peripheral nerves. A schematic representation of the “floxed” 
Itg 1 allele shows that two loxP sites (red) flank exon 2, containing 
the ATG start site of translation and the P0Cre-mP0TOT(Cre) transgene, 
containing the Cre gene inserted into exon 1 of the Mpz gene. 
Transverse sections of control (B; wt) or mutant (C; mt) sciatic nerves 
at P28 show that  1 is normally detected in the endoneurium at the 
outer surface of each myelinating Schwann cell (arrowheads) and in 
the perineurium (arrows), whereas in mutant nerves,  1 is absent in 
Schwann cells (asterisk), but is preserved in the perineurium 
(arrows). Low level endoneurial staining for  1 is associated with 
vessels and perineurial cells abnormally present in the endoneurium 
(C; see text). (D–F) Double staining of DRG for neurofilament 
(D; green) and  1 integrin (E; red) shows that  1 expression in 
mutant sensory neurons is preserved; (F) merge. Longitudinal 
sections of control (G and I) and mutant (H and L) nerves at E17.5 
are double stained for  1 (G and H; green) and LNGFR (I and L; 
red). Note that the  1 integrin staining in Schwann cells is markedly 
reduced in mutant nerves by E17.5. Bar: (B and C) 30  m; (D and F) 
50  m; (G and I) 60  m; (H and L) 90  m. 
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present within the endoneurium (see below). Thus, 
 
 
 
1 inte-
grin is absent in most, if not all, Schwann cells in nerves of
adult mutant mice (see also below).
Schwann cells originate from multipotent neural crest
precursors that also give rise to other components of pe-
ripheral nerve, DRG neurons, which contribute axons to
peripheral nerves (Anderson, 1997). P
 
0
 
 mRNA is expressed
at low levels in some neural crest precursors (Lee et al.,
1997). Consistent with this, another P
 
0
 
Cre transgene acti-
vates recombination as early as E9.5 in the neural crest,
producing somatic genomic alterations inherited by both
Schwann cells and DRG neurons (Yamauchi et al., 1999).
To determine if our P
 
0
 
Cre transgene targeted recombina-
tion only to Schwann cells, we stained DRG of adult mu-
tant mice for 
 
 
 
1 integrin and neurofilament, a neuronal
 
marker. Fig. 1, D–F, shows that DRG neurons from mutant
mice coexpress neurofilaments and 
 
 
 
1 integrin. In addi-
tion, when our P
 
0
 
Cre mouse was crossed with a discontinu-
ous 
 
lac
 
Z “tester” mouse (Akagi et al., 1997), we never de-
tected 
 
lac
 
Z expression in DRG neurons (unpublished data).
Therefore, DRG neurons and perineurial cells of mutant
mice still express 
 
 
 
1 integrin, whereas Schwann cells do
not; any phenotype observed in nerves of mutant mice is
Schwann cell autonomous.
Figure 2. Mutant mice manifest severe motor impairment. (A–D) 
Mutant (mt) and control (wt) mice at P28 (A and B) or P90 (C and D) 
were observed sitting on an inclined surface (A and B) or walking on 
a flat surface (C and D). Mutant mice at P28 sit with their hind limbs 
displaced laterally (arrow in B) and walk with a wider base, swinging 
their hind limb laterally (unpublished data). By P90, many mutant 
mice manifest nearly paralyzed hind limbs (arrows in C) and more 
obvious muscle atrophy (arrow in D). (E) Rotarod test was performed 
with 2–3-mo-old mutant and control mice. In a series of seven 
consecutive trials the time (seconds; mean   SEM) for which 
animals remained on a rod rotating at increasing speed is plotted. 
Hold time is significantly reduced in mutant mice (n   10) as 
compared with control mice (n   14). 0.01   P   0.001 in the first 
trial, and P   0.001 in subsequent trials, by two-tailed Student 
t test. Bar: (A–C) 3 cm; (D) 2.7 cm.
Figure 3. Mutant mice develop a severe dysmyelinating neuropathy. 
Transverse semithin sections of comparable nerves from mutant 
(mt; A, C, E, and G) and control (wt; B, D, F, and H) mice at E17.5 
(A and B), P5 (C and D), P15 (E and F), and P28 (G and H). At P28, 
myelination is complete in normal nerves (H), whereas mutant 
nerves show large bundles of unsorted axons (G, arrowheads) and 
few myelinated fibers (arrows). At E17.5 (A and B) both control and 
mutant nerves contain groups of yet unsorted axons (asterisks)
and numerous Schwann cells between them (arrows); groups of 
tightly packed axons begin to be distinguishable in mutant nerves 
(A, arrowheads), but not in controls (B). In P5 control nerves (D), 
most large caliber axons have reached the proper 1:1 relationship 
with a Schwann cell, and many thin myelin sheaths appear. In mu-
tant nerves (C), in contrast, large groups of unsegregated axons are 
present (arrowheads), and only rare, very thin, myelin sheaths have 
formed. Unsorted groups of axons become progressively more 
obvious during nerve maturation (E and G, arrowheads), and are 
often grouped sectorially in the nerve. More thin myelin sheaths 
appear with delay in mutant nerves at P15 (E) and become thicker at 
P28 (G). Bar: (A and B) 27  m; (C–H) 29  m. 
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Mice lacking 
 
 
 
1 integrin in Schwann cells develop a 
severe dysmyelinating neuropathy
 
Mutant mice manifested progressive muscular weakness, ap-
pearing in the first 2 wk of life and evolving to hind limb pa-
ralysis by 3–5 mo of life (Fig. 2, C and D). Tremor, wide-
based gait, and muscular atrophy were already evident by
P28 (Fig. 2 B). This phenotype was variably severe, even
among littermates. To quantify the neuromuscular deficit,
we performed a rotarod behavioral test. 2–3-mo-old mutant
and control mice were placed on a horizontal rod rotating at
increasing speed, and the time that they remained on the bar
was measured. Mutant mice remained on the rod for signifi-
cantly less time than control mice (Fig. 2 E).
We next examined the morphology of mutant and control
sciatic nerves at P28 by analysis of transverse semithin sec-
tions or by electron microscopy. By this age every large cali-
ber axon in a normal nerve has been myelinated (Fig. 3 H).
In contrast, sciatic nerves from mutant mice show few my-
elinated axons (Fig. 3 G). Several axons had achieved an ap-
propriate 1:1 relationship with a Schwann cell, but were not
myelinated. Instead, most axons were tightly packed in large
bundles, and not ensheathed by Schwann cells. These bun-
dles of axons were surrounded by a ring of cells. Ultrastruc-
tural analysis revealed that some of these encircling cells
lacked a basal lamina, and were presumably endoneurial fi-
broblasts. However, most frequently these cells displayed a
basal lamina, caveolae, tight junctions, and lipid inclusions,
identifying them as peurineurial-like cells (Fig. 4, A, B, and
G). In addition, they stained for both 
 
 
 
1 integrin (Fig. 1 C)
and for occludin (unpublished data), a perineurial cell
marker (Furuse et al., 1993; Parmantier et al., 1999), con-
firming that significant numbers of perineurial-like cells are
found within the endoneurium of mutant, but not normal
nerves. Sciatic nerves of older mice (up to 6 mo of age) ap-
Figure 4. Ultrastructural analysis of 
mutant nerves reveals perturbed 
relationships with axons. Transverse 
sections of mutant sciatic nerves at P28 
(A and B) reveal bundles containing 
unsorted, mixed caliber axons (asterisks) 
that are not invested by Schwann cell 
cytoplasm (“naked”). Several Schwann 
cells have attained the proper 1:1 rela-
tionship with an axon and occasionally 
are forming a myelin sheath (A). At high 
magnification (C), the periodicity of com-
pact myelin appears normal. Axonal 
bundles are always surrounded by a layer 
of perineurial cells, abnormally present in 
the endoneurium (arrowheads). Some of 
the perineurial cells contain lipid 
inclusions (B) and at high magnification 
(inset in B–G) display a basal lamina 
(arrowhead in G), tight junctions (arrow 
in G), and caveolae (arrows in insets 
indicated by asterisks in G; magnified 
1.6 ). In D–F several axons are shown 
surrounded by a loose, undulated basal 
lamina (arrowheads), which in some 
cases contain Schwann cell processes 
variably ensheathing axons (arrows), 
whereas in C, a myelinated fiber has a 
tightly apposed basal lamina (arrow-
heads). Transverse sections of control (H) 
and mutant (I) nerves at P1 show differ-
ences in radial sorting and cytoplasmic 
processes. In control nerves (H), most 
axons  1  m are either segregated at the 
periphery of a bundle (black asterisks), in 
groups of 1–3 (arrows), or clearly in a 1:1 
relationship with a Schwann cell. In con-
trast, in mutant nerves (I), most large 
axons are either unsegregated from bun-
dles of smaller axons (black asterisks), or 
in groups of greater than three (thick 
arrows). Whereas control Schwann cells 
(H) send thin processes around axons, 
mutant Schwann cells (I) send abnormally 
shaped, thick cytoplasmic processes 
(white asterisks) in every direction (thin 
arrows). Bars: (A) 4.4  m; (B) 3.7  m; 
(C and G) 1.2  m; (D and E) 1.6  m; (F) 1 
 m; (H and I) 7.6  m. 
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peared similar in semithin sections (unpublished data).
Whether axonal degeneration and fiber loss occurs in distal
nerves of older animals remains to be determined.
 
 
 
1-null Schwann cells variably retract their processes 
from ensheathed axons
 
The bundles of naked axons, not ensheathed by Schwann
cell cytoplasm, were particularly interesting, because they are
the hallmark feature of spinal roots in 
 
dystrophic
 
 mice. Typi-
cally they were more numerous in one or two fascicles of the
nerve. By ultrastructural analysis (Fig. 4, A and B) we identi-
fied occasional Schwann cells at the margin or within bun-
dles, in various stages of axonal ensheathment or myelina-
tion. Other fascicles contained only Schwann cells engaged
in normal axonal relationships—Schwann cells in a 1:1 rela-
tionship with large diameter axons and normal nonmyelin–
forming Schwann cells ensheathing multiple small axons
(Fig. 4 B and unpublished data). Many Schwann cells had
no myelin, but others formed myelin sheaths of various
thickness (Fig. 4, A and B), and of normal periodicity (Fig. 4
C). Thus, at least some Schwann cells could bypass the im-
pairment of sorting axons and differentiate normally toward
myelin-forming or nonmyelin-forming phenotypes.
 
 
 
1 integrin adheres to extracellular matrix components,
such as laminin, in the basal lamina (Previtali et al., 2001).
Mutant nerves contained some basal laminae that were con-
tinuous and adherent to the Schwann cell surface (Fig. 4 C).
However, many Schwann cells produced a basal lamina that
was either discontinous, or continuous but detached at
points from the cell surface. Strikingly, many axons were
surrounded by an empty, undulated basal lamina. Inside, we
found Schwann cell cytoplasmic processes ranging from par-
tially ensheathing, to only in tangential contact with an
axon, to completely absent (examples are shown in Fig. 4,
D–F), suggesting that a Schwann cell had originally en-
sheathed a single axon and then retracted its process. These
data indicate that, in the absence of 
 
 
 
1 integrin, many
Schwann cells are unable to maintain normal contact with
their basal lamina and consequently normal interactions
with axons. We imagined that bundles of naked axons could
result from both arrest in the process of radial sorting and re-
traction of ensheathing processes.
 
 
 
1-null Schwann cells fail to ensheath and segregate 
axons in developing nerves
 
To further address the formation of bundles of naked axons,
we examined developing nerves from mutant animals. Ax-
onal segregation and sorting is normally largely complete by
the first few days after birth (Fig. 3 D). In mutant nerves,
bundles of tightly apposed axons were already distinguish-
able at E17.5 (Fig. 3 A) and became progressively more ob-
vious with nerve maturation (Fig. 3, C, E, and G). By im-
munohistochemistry, we confirmed that 
 
 
 
1 integrin was
mostly absent from Schwann cells by E17.5 (Fig. 1 H and
see below).
We next examined the ultrastructure of nerves at E17.5
and P1, when sorting and segregation normally produce
promyelinating Schwann cells. At E17.5, some mutant
Schwann cells had advanced cytoplasmic processes around
axons, but these processes appeared redundant and disorga-
nized as compared with controls (unpublished data). In con-
trol nerves at P1, most axons larger than 1 
 
 
 
m in diameter
had already been segregated to the periphery of axonal bun-
dles, or were already ensheathed by single Schwann cells
(Fig. 4 H). Occasionally, we identified Schwann cells con-
taining two or at most three large caliber axons. Small cali-
ber axons, not destined to be myelinated, remained within
bundles. Schwann cell processes were thin, with little cyto-
Figure 5.  1-null Schwann cells proliferate and survive normally. 
(A–C) Nuclei of mutant Schwann cells associated with longitudinal 
sections of nerves at E17.5 that have been stained for neurofilament 
(A, green) and BrdU (B, red) after a 1-h pulse; C, merge. (D–F) Apop-
totic nuclei associated with mutant nerves at E17.5 that have been 
stained for neurofilament (NF) (D, green) were identified by TUNEL 
staining (E, red); F, merge. (G) The percentages (mean   SEM) of 
BrdU- or TUNEL-positive nuclei in mutant (mt) and control (wt) 
nerves. See also Table I. By a paired, two-tailed t test the percentages 
in mutant and controls were not significantly different. Bar, (A–F) 
60  m. 
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plasmic content, and uniformly distributed around axons or
axon bundles.
In contrast, mutant nerves at P1 contained Schwann cells
that had ensheathed groups of up to 8–9 large caliber axons,
and bundles of unsorted, mixed caliber axons (Fig. 4 I).
Strikingly, Schwann cell processes contained a larger volume
of electron-dense cytoplasm and expanded in many direc-
tions, even away from axons. All processes were surrounded
by a basal lamina; there was as yet no evidence of retraction
of cytoplasmic processes. Thus, both impaired initial inter-
actions with axons, as well as subsequent retraction of pro-
cesses, may contribute to bundle formation.
 
Mutant Schwann cells populate nerves, proliferate, and 
die normally
 
One alternate explanation for bundles of naked axons was
that the number of 
 
 
 
1-null Schwann cells were insuffi-
cient to ensheath axons, due to a failure in their migra-
tion, proliferation, or survival. 
 
 
 
1 integrins are involved
in these processes in other cells (for review see De Arcan-
gelis and Georges-Labouesse, 2000). Furthermore, as a
source of mitogenic and survival factors (e.g., neuregu-
lins), axons are a major determinant of Schwann cell
number (Meyer and Birchmeier, 1995; Riethmacher et
al., 1997; Wolpowitz et al., 2000). Thus, impaired rela-
tionships between mutant Schwann cells and axons could
also reduce survival or proliferation.
Schwann cells in mutant nerves had migrated distally be-
cause comparable numbers of cells were visible within distal
nerves of mutant and control mice at E15.5, E17.5, and P1
by DAPI and neurofilament staining in nerves of whole fe-
tuses (Fig. 5), including in superficial nerves adjacent to the
skin (unpublished data), or by semithin section analysis in
nerves distal to the knee (Fig. 3 A and unpublished data).
This is not surprising, as Schwann cell precursors populate
the length of nerves before recombination by P
 
0
 
Cre at
E13.5–E14.5. To determine if there was a failure in
Schwann cell proliferation, we measured the percentage of
nuclei incorporating BrdU in nerves of E15.5 and E17.5
 
Table I. 
 
Measurements of proliferation and apoptosis in mutant and control nerves
BrdU incorporating nuclei TUNEL-positive cells
Age mt wt mt wt
 
%% % %
 
E15.5 24.6 
 
  
 
3.4(10) 23.7 
 
 
 
 3.0 (11) 1.95 
 
 
 
 0.67 (32) 1.96 
 
 
 
 0.75 (12)
E17.5 35.5 
 
 
 
 2.5(6) 28.3 
 
  3.6 (7) 0.21   0.17 (24) 0.18   0.10 (23)
P5 0.74   0.18 (14) 0.54   0.12 (11)
Percentages (mean   SEM) of nuclei incorporating BrdU and of TUNEL-positive cells in nerves of mutant (mt) and control (wt) mice. Number of experiments
is in parentheses. By a paired, two-tailed t test, the percentages in mutant and control animals were not significantly different.
Figure 6. Synthesis of other laminin receptors and myelin in  1-null Schwann cells. Transverse sections of sciatic nerves from control (wt) 
(A and B) and mutant (mt) (E and F) mice at P28 were double stained for MBP (A and E; green) and  1 integrin (B and F; red). In the control 
nerve, every MBP-positive myelin sheath is encircled by a  1-positive Schwann cell cytoplasm, whereas in the mutant nerve, the MBP-positive 
myelin sheaths are not. Staining of serial sections from the same mutant nerve for dystroglycan (DG; G),  4 integrin (H), and  6 integrin (I) 
detects multiple myelinated fibers in the same field (next to an asterisk as a point of reference) positive for  6,  4 integrin, and dystroglycan. 
Transverse sections of spinal roots of mutant mice at P28 double stained for MBP (C) and  1 integrin (D) reveal numerous MBP-positive fibers 
with no associated  1 integrin. Bar: (A and B) 20  m; (C and D) 40  m; (E–I) 70  m.  1 integrin regulates Schwann cell–axon interactions | Feltri et al. 205
mice. We found no significant difference in BrdU incorpo-
ration in mutant and control nerves (Fig. 5 and Table I), in-
cluding at E17.5, the peak of Schwann cell proliferation
(Stewart et al., 1993). To determine if  1-negative Schwann
cells died by apoptosis more often than control Schwann
cells, we measured the fraction of nuclei stained by terminal
deoxynucleotidyl transferase–mediated dUTP-biotin nick-
end labelling (TUNEL) in mutant and control nerves at
E15.5, E17.5, and P5. The percentages were not signifi-
cantly different in mutant and control nerves (Fig. 5 and Ta-
ble I). The percentages in control nerves are in agreement
with those previously reported in rat (Grinspan et al., 1996;
Syroid et al., 1996) and mouse (Syroid et al., 2000). Thus,
we found no major difference in migration, proliferation,
and apoptosis of mutant Schwann cells. It should be noted
that  1 class integrins probably play a role before E13.5–
E14.5 in the processes of migration, proliferation, and sur-
vival in Schwann cell precursors (Lefcort et al., 1992; Milner
et al., 1997; Haack and Hynes, 2001). These data further
support that axons within empty or partially empty basal
laminae are produced by process retraction, not death of
Schwann cells, at least until P5.
Schwann cells can synthesize myelin in the absence of 
 1 integrin
We identified ultrastructurally normal myelin sheaths in
mutant sciatic nerves at P28 (see above). These findings
were surprising, because previous antibody-blocking experi-
ments in Schwann cell–DRG cocultures suggested that  1
integrin was necessary for myelination (Fernandez-Valle et
al., 1994). One possible explanation was that some Schwann
cells escaped Cre-mediated recombination and expressed  1
integrin. To test this, we stained nerves and spinal roots
from adult mutant and control mice for  1 integrin and my-
elin basic protein (MBP), a myelin marker. In control
nerves, each myelin sheath appeared as an MBP-positive
ring (Fig. 6 A, green), encircled by a thin  1-positive ring at
the abaxonal surface of the Schwann cell (Fig. 6 B, red). In
contrast, in mutant nerves, the few MBP-positive myelin
sheaths were not encircled by  1-positive rings (Fig. 6, E
and F). This finding was more striking in nerve roots, where
the majority of Schwann cells had achieved a 1:1 relation-
ship with large axons and formed myelin. Here, none of the
multiple MBP-positive myelin sheaths were surrounded by a
 1-positive ring (Fig. 6, C and D).
Alternatively, the ablation of  1 could have been delayed
long enough in some Schwann cells to permit myelination
to proceed before  1 disappeared. This could result from ei-
ther delayed recombination by Cre or from a long half-life
of  1 integrin. To test these possibilities, we stained nerves
at E15.5, E17.5, and P5 for  1, low affinity nerve growth
factor receptor (LNGFR) (or S-100 at P5), a marker of pre-
myelinating Schwann cells, and occludin, a marker of
perineurial cells and blood vessels (Furuse et al., 1993; Par-
mantier et al., 1999). At E17.5 or later, we detected minimal
 1 staining in the endoneurium of mutant nerves that colo-
calized with occludin (unpublished data) but not with
LNGFR, showing that the cells expressing  1 are perineurial
cells or vessels. In sharp contrast, the cytoplasm of the ma-
jority of cells in the endoneurium of control nerves stained
for  1 and LNGFR, but not occludin (Fig. 1, G–L, and un-
published data). Thus, in mutant nerves, premyelinating
Schwann cells had already lost  1 by E17.5. This observa-
tion fits well with the finding that our P0Cre recombines a
“tester” lacZ transgene along the length of peripheral nerves
by E15.5 (unpublished data). The sum of the above data
clearly shows that Schwann cells can synthesize myelin in
the absence of  1 integrin. Moreover, it suggests that those
Schwann cells that can form appropriate relationships with
axons, and subsequently synthesize myelin, exploit other fac-
tors in the process.
In keeping with this idea, it was possible that myelination
in mutant nerves depended on laminin receptors that substi-
tuted for  1 function. Serial sections from the nerve in Fig.
6 were stained for other laminin receptors not containing
 1, and known to be expressed in Schwann cells: dystrogly-
can and  6 4 integrin (Einheber et al., 1993; Feltri et al.,
1994; Yamada et al., 1994).  1-null, myelinated fibers con-
tained dystroglycan,  4, and  6 integrins (Fig. 6, G–I).
Myelination is delayed in the absence of  1 integrin, 
despite the perinatal appearance of other
laminin receptors
To further explore whether these laminin receptors com-
pensate for the absence of  1, we compared the onset of
myelination with that of dystroglycan and  4 integrin
synthesis in developing mutant nerves. Myelination began
later than normal in mutant nerves. Numerous thin my-
elin sheaths were visible in normal nerves at P5 (Fig. 3 D),
whereas virtually no myelin was present at this age in mu-
Figure 7. Myelination is delayed 
despite normal onset of dystroglycan 
synthesis in mutant nerves. Longitudinal 
sections of control (wt) (A–C) and mutant 
(mt) (D–F) nerves at P1 were double 
stained for dystroglycan (A and D; red) 
and MBP (B and E; green). In all nerves, 
dystroglycan is detected in multiple 
fibers (A, C, D, and F), but only in 
control nerves do a subset of these fibers 
stain for MBP (compare B to E). Bar: 
(A–F) 60  m.206 The Journal of Cell Biology | Volume 156, Number 1, 2002
tant nerves (Fig. 3 C). Several myelin sheaths, thinner
than those of littermate controls, were first evident at P15
(Fig. 3, E and F). At P28, thick myelin sheaths of normal
periodicity were seen in both mutant and control nerves
(Fig. 3, G and H). Dystroglycan expression immediately
precedes myelination in normal nerves around birth (un-
published data). Thus, we stained nerves at P1 for dystro-
glycan and MBP. Dystroglycan was expressed in many fi-
bers of normal nerves at this age, a subset of which had
initiated MBP synthesis and myelination (Fig. 7, A–C). In
mutant nerves, dystroglycan was also found in many fi-
bers, but no MBP was detected (Fig. 7, D–F), consistent
with delayed myelination. Similarly,  4 integrin appeared
simultaneously in control and mutant nerves at P1 (un-
published data) in advance of significant myelin forma-
tion in mutant nerves (Fig. 3). Thus, dystroglycan and
 6 4 integrin may compensate for  1 integrins in my-
elination, but they are not limiting. Other factors must
intervene to permit the (delayed) onset of myelination in
 1-ablated Schwann cells.
Discussion
We describe mice in which  1 integrin was ablated specifi-
cally in Schwann cells in the late embryo using the Cre-loxP
system. The lack of  1 integrin causes a severe dysmyelinat-
ing neuropathy due to the inability of Schwann cells to form
and maintain proper interactions with axons.  1 integrin is
not required at this time for Schwann cell migration, prolif-
eration, and survival. Rather, ultrastructural changes in mu-
tant nerves suggest that  1 is necessary to reorganize the cy-
toskeleton as Schwann cells ensheath axons and acquire the
promyelinating phenotype. Interestingly, some Schwann
cells can bypass the impaired axonal interaction even in the
absence of  1 integrin and synthesize normal myelin, albeit
with a delay. This data shows that Schwann cells require  1
integrins in order to segregate axons, and attain the proper
1:1 relationship with an axon, which is a prerequisite for
myelination.
P0Cre directs Schwann cell–specific inactivation of  1
Using the transgenic vector mP0TOTA (Feltri et al.,
1999b), we produced transgenic mice in which P0Cre directs
recombination specifically in Schwann cells of peripheral
nerves beginning at E13.5–E14.5, as revealed by lacZ
“tester” mice (Feltri et al., 1999a, and unpublished data).
Similarly, in P0Cre// 1
F/  mice,  1 integrin was ablated in
virtually all Schwann cells, whereas it remained in perineur-
ial cells and DRG sensory neurons and their axons. This is
particularly relevant because DRG neurons and Schwann
cells derive from common neural crest precursors, some of
which express P0 mRNA (Lee et al., 1997). The above data
show that the observed phenotype is Schwann cell autono-
mous. Of note, this is the only transgenic mouse in which
the expression of Cre has been targeted to Schwann cells and
recombination in DRG neurons has been excluded experi-
mentally (Akagi et al., 1997; Voiculescu et al., 2000). In-
stead, another P0Cre mouse has been reported to target re-
combination to both Schwann cells and DRG neurons
(Yamauchi et al., 1999).
 1 integrin is required for Schwann cells to interact 
properly with axons
Process extension, axonal ensheathment, and spiral wrap-
ping allow Schwann cells to form myelin. Many lines of evi-
dence suggest that these changes in cell shape are mediated
by the cytoskeleton and its linkage to the extracellular matrix
(Bunge and Bunge, 1983; Fernandez-Valle et al., 1997). In
mutant nerves, we observed several abnormalities that indi-
cate an alteration of the cytoskeleton or its linkage. First, at
the time of axonal ensheathment and sorting (between
E17.5 and P1), Schwann cell processes are hypertrophic and
are expanded in random directions. Second, associated with
these morphological abnormalities, Schwann cells aberrantly
ensheath groups of large diameter axons, or are unable to
segregate them from small axons. Third, strong indirect evi-
dence suggests that some Schwann cells initially ensheath ax-
ons, but subsequently retract their processes: at P28, many
axons are surrounded by a basal lamina, either “empty” or
containing Schwann cell processes that incompletely cover
the axon. This indicates that Schwann cells once ensheathed
the axon, synthesized the basal lamina, and then either died
or retracted their processes. Since the amount of apoptosis
during matching of Schwann cell and axon numbers is not
significantly increased in mutant nerves, we conclude that
Schwann cells must be unable to maintain process extension.
All of these characteristics (cell shape, formation, and
maintenance of cytoplasmic processes) require dynamic
alterations of the cytoskeleton.  1-containing integrins
transmit signals that cause rearrangement of the actin-
based cytoskeleton (Schoenwaelder and Burridge, 1999). In
Schwann cells,  1 integrin associates with focal adhesion ki-
nase, fyn kinase, paxillin, and F-actin (Chen et al., 2000).
Moreover, Rho family GTP-ases that normally function in
regulating actin polymerization are expressed and active in
Schwann cells (Terashima et al., 2001), and actin depoly-
merization alters Schwann cell differentiation (Fernandez-
Valle et al., 1997). It is therefore likely that ablation of  1
integrin results in abnormal cytoskeletal organization, caus-
ing failure of axonal ensheathment. Indeed, the lack of  1
integrin perturbs cell shapes in other cell types (Stephens et
al., 1993; Fassler et al., 1995).
 1 integrin and myelination
Two reports have shown that  1-blocking antibodies pre-
vent myelination in cocultures of Schwann cells and DRG
neurons (Fernandez-Valle et al., 1994; Podratz et al., 2001).
Thus, it was surprising to find that  1-negative Schwann
cells can form normal myelin. Of note, Fernandez-Valle et
al. (1994) have shown that high doses of  1-blocking anti-
bodies indeed impair the ability of Schwann cells to sort ax-
ons in the DRG cocultures, consistent with our data. It is
possible that higher amounts of antibodies are required to
mimic the  1-ablated phenotype, with impaired sorting and
ensheathment of axons, whereas lower doses of antibodies
perturb axonal relationships subtly, and secondarily block
myelination.
Instead, we propose that  1 integrin is most important for
Schwann cells to reach the promyelinating stage, Schwann
cells in a 1:1 relationship with an axon (Zorick et al., 1996;
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pass the arrest and reach this stage with a few days delay.
Once the promyelinating stage is reached, Schwann cells can
eventually myelinate. Other laminin receptors, such as  6 4
integrin and dystroglycan, probably compensate or are re-
dundant for the function of  1 integrins.
Despite the normal timing of appearance of  6 4 inte-
grin and dystroglycan in mutant nerves, myelination is de-
layed. Many large caliber axons have achieved 1:1 relation-
ships with mutant Schwann cells by P5 (Fig. 3), but
significant myelination awaits P15. Thus, something else,
not axonal relationship and not known laminin receptors, is
limiting. Either new factors compensate but appear with de-
lay, or Schwann cells need time to correct discoordinated ex-
pression or function of existing factors.
Basal lamina and  1 integrin
Basal lamina is first organized around “families” of Schwann
cells that encircle bundles of axons before radial sorting (Web-
ster, 1984) at the time that  1 is disappearing from mutant
nerves. In fact, we show that genetic alterations of either lami-
nin (dystrophic mice) or  1 integrin produce similar abnor-
malities in basal lamina and radial sorting. Thus, a functional,
and probably physical, interaction between laminin and  1
integrin is required for normal radial sorting leading to the
promyelinating Schwann cell phenotype. In support of this,
the morphology of basal lamina in  1-null promyelinating
Schwann cells is altered: basal lamina are no longer adherent
to the surface of many Schwann cells and are sometimes dis-
continuous. This could represent lack of adhesion at the
Schwann cell surface in the absence of  1, or a lack of appro-
priate basal lamina organization by  1 integrin.
Implications for the pathogenesis of CMD
 1-ablated nerves strikingly resemble the spinal roots and
proximal nerves of dystrophic mice deficient in laminin-2.
The Schwann cell basal lamina is discontinuous, or altered,
and radial sorting is impaired, producing bundles of naked,
mixed caliber axons. Finally, the ensheathing defect appears
progressively in developing nerves just as it does in newborn
dystrophic roots (Jaros and Bradley, 1978). It is interesting
that the topography of impaired sorting differs between the
two; it is most severe in the spinal roots of dystrophic mice
and in the nerves of  1-ablated mice. We cannot eliminate
the possibility that loss of a  1 function unrelated to lami-
nin contributes to the phenotype of our mice. The  1 inte-
grin subunit can interact with multiple   subunits, forming
dimeric receptors with differing ligand specificities, many of
which are present in Schwann cells (laminin:  1 1,  2 1,
 3 1, and  6 1; fibronectin:  4 1 and  5 1; collagen:
 1 1,  2 1, and  3 1) (Lefcort et al., 1992; Milner et al.,
1997; Previtali et al., 2001). However, another appealing ex-
planation is that the topographical difference in severity re-
sults from compensation for laminins that does not parallel
that for  1 integrins in time or place in developing nerves
and roots. Nonetheless, the striking morphological similarity
between the two mutants, and the fact that laminin-2 de-
fects appear before birth when the only laminin receptors
present in nerve contain  1, indicates that  1 integrins are
functionally downstream of laminin-2 in a pathway that reg-
ulates Schwann cell–axon interactions.
In conclusion, this study answers several longstanding and
important questions. First, laminin 2 mutations have their
effect through loss of  1 integrin function, rendering
Schwann cells unable to segregate and ensheath axons perin-
atally. Second, the mechanism in dystrophic mice is very
likely to involve uncoupling of the basal lamina from the cy-
toskeleton, such that the Schwann cell cannot reorganize its
cytoskeleton to change shape appropriately. Third,  1 inte-
grin is not directly required to form myelin, but to achieve
the proper 1:1 promyelinating Schwann cell–axon relation-
ship. Since laminin mutations are involved in CMD, and
peripheral nerve dysfunction is an important contributor to
the CMD phenotype (Kuang et al., 1998), understanding
the molecular basis of how  1 signals to the cytoskeleton
(with which   integrin partner and by which transduction
pathways) will provide important clues to the pathogenesis
of dysmyelination in CMD.
Materials and methods
Transgenic mice
 1-deficient mice and  1-floxed mice have been described (Stephens et
al., 1995; Graus-Porta et al., 2001). mP0TOTA(Cre) (hereafter P0Cre) has
been described previously (Feltri et al., 1999a). The mP0TOTA monomer
contains a complete mouse P0 gene with 6 kilobases of promoter, in which
the ATG start of translation has been mutated and substituted with Cre (Fig.
1). The P0Cre line used in this paper, Tg98.1 (TgN[MpzCre]26Mes), was
maintained by backcrosses to FVB/N mice. Mice heterozygous for the  1-
null allele ( 1
 / ), in a 129Sv/B6 mixed background were crossed with
P0Cre mice to obtain P0Cre// 1
 /  mice. These were then crossed with
mice homozygous for  1-floxed ( 1
F/F), also in a 129Sv/B6 mixed back-
ground, to obtain P0Cre// 1
F/  (hereafter mutant) or  1
F/ ,  1
F/ , or P0Cre//
 1
F/  (hereafter wild-type) mice.  1
F/  were used as controls in most exper-
iments, but occasionally  1
F/  or P0Cre// 1
F/  were added as controls; all
three genotypes were associated with normal phenotypes. P0Cre// 1
 / 
and  1
F/  parents were maintained by backcrosses with C57BL6. Most
progeny in this study resulted from parents that were N2–N5 generations
congenic for C57BL6. Transgenic progeny were identified by Southern blot
and PCR analysis of genomic DNA prepared from tail or other tissues sam-
ples as described previously (Stephens et al., 1995; Feltri et al., 1999a;
Graus-Porta et al., 2001).
Behavioral analysis
Posture and gait of mutant and control animals from 1 to 6 mo of age were
observed on a smooth plastic surface inclined at 30  relative to horizontal.
For Rotarod analysis, groups of 2.5–3 mo old mutant and control litter-
mates were placed on a round metal bar rotating first at 4 rotations per
minute (rpm) and then accelerating at 7.2 rpm
2 (Ugo Basile). The animals
were allowed to stay on the rod for a maximum of 700 s and the time of
hold on the rotating rod was measured in subsequent trials (4 trials in the
first 2 d and 1 trial on each of 3 consecutive days).
Morphological analysis
Mutant and control littermates were killed at the ages indicated, semithin
and ultrathin morphological analyses of nerves were conducted as de-
scribed previously (Wrabetz et al., 2000).
Immunohistochemistry
Complete fetuses, or the spinal column, the posterior limbs, or the sciatic
nerve for post-natal animals, were collected in PBS and either directly, or
after overnight fixation in 4% paraformaldehyde in 0.1M PBS at 4 C, cryo-
protected in 20% sucrose, embedded in OCT (Miles), and snap-frozen in
liquid nitrogen. Indirect immunofluorescence was performed on 8- m
thick cryosections fixed in cold acetone for 2 min, rinsed twice in PBS, and
blocked with either 10% normal goat serum (Dako) or 20% calf or horse
serum, 1% bovine serum albumin, 0.1% Triton X-100, and 0.05% sodium
azide. The following antibodies were used: polyclonal antibody (pAb)
anti– -dystroglycan (AP83; a gift of K. Campbell, Howard Hughes Medical
Institute, Iowa City, IA); mAb anti– 6 integrin (GoH3, a gift of A. Sonnen-
berg, The Netherlands Cancer Institute, Amsterdam); pAb anti- 1 integrin
(a gift of K. Rubin, Biomedical Center, Uppsala, Sweden); mAb anti- 1 in-208 The Journal of Cell Biology | Volume 156, Number 1, 2002
tegrin MB1.2, pAb anti-200-kD neurofilament, and pAb anti-LNGFR
(Chemicon International); pAb anti- 4 integrin (a gift of V. Quaranta, The
Scripps Research Institute, La Jolla, CA); mAb anti- 4 integrin (gift of S.J.
Kennel, National Laboratory, Oak Ridge, TN); mAb anti-MBP and mAb
anti-neurofilament TA51 (gifts of V. Lee, University of Pennsylvania, Phila-
delphia, PA); mAb anti-160-kD neurofilament (NN18) and mAb anti-BrdU
(Roche); pAb anti-occludin (Zymed Laboratories); pAb anti S-100 (Sigma-
Aldrich). Secondary antibodies included: FITC- or TRITC-conjugated goat
anti–mouse, –rat, or –rabbit IgG (Southern Biotechnology Associates, Inc.).
To reduce background staining produced with mouse mAbs in mouse tis-
sue, we used in some instances the mouse-to-mouse Dako ARK-kit (Dako).
Sections were examined with a confocal (MRC 1024; Bio-Rad Laborato-
ries) or fluorescence microscope (Olympus AX-70).
BrdU incorporation assay
BrdU incorporation was performed according to Stewart et al. (1993), with
few modifications. Briefly,  1
 / //P0Cre females were mated with  1
F/F
mice, and 15 or 17 d after detection of a plug they were injected intraperi-
toneally with 100  g BrdU/g body weight. 1 h later, fetuses were dissected;
the upper body was used to determine genotype and the lower body was
processed for immunohistochemistry, with no fixation (as above). Cryosec-
tions from at least 2 to 3 each of mutant or control fetuses were fixed in
cold methanol, treated with 2 N HCl for 15 min at 37 C, and neutralized
with 0.1 M sodium borate pH 8.5 for 10 min. Slides were then incubated
with mAb antineurofilament, to identify nerves, and mAb anti-BrdU (see
above). After staining with secondary antibodies, nuclei were counter-
stained with DAPI. Only cigar-shaped nuclei associated with nerves were
counted, and the fraction of BrdU-positive nuclei was determined. At least
300 nuclei at E15.5 and 900 nuclei at E17.5 were examined.
TUNEL assay
TUNEL assay was performed as described by Grinspan et al. (1996), with
few modifications. Briefly, E15.5 and E17.5 fetuses or P5 sciatic nerves
were dissected, fixed in 4% paraformaldehyde in PBS for 1 h, then cryo-
preserved for immunohistochemistry as above. At least three fetuses and
two P5 animals for each of the mutant or control genotypes were studied.
Cryosections were treated with acetone, stained with antibodies, and then
processed for TUNEL. P5 nerves were stained with anti- 1 integrin or anti-
S100 antibodies (unpublished data), and fetuses were stained with an-
tineurofilament antibodies to identify nerves (Fig. 5). TUNEL staining was
then performed exactly as described (Grinspan et al., 1996). Nuclei were
counterstained by DAPI. For quantification, only DAPI-positive nuclei as-
sociated with nerves were counted and the fraction of TUNEL-positive nu-
clei was determined. At least 1,000 nuclei at E15.5, 3,500 at E17.5, and
10,000 nuclei at P5 were examined.
Image analysis
Micrographs were digitalized using an AGFA Arcus 2 scanner, and figures
were prepared using Adobe Photoshop
® version 5.0.
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